Noticias de NERV_US

Noticias del mercado

Últimas noticias sobre NERV_US — 47 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: NERV_US ✕ 47 resultados
02/04/2026 NERV_US — Stock Titan
Leadership shift at Minerva Neurosciences (NASDAQ: NERV) as O’Connor joins
02/04/2026 NERV_US — Investing.com ES ← EN
Minerva Neurosciences nombra a Jim O'Connor director comercial
02/04/2026 NERV_US — NTB Kommunikasjon ES ← EN
Minerva anuncia transición de liderazgo
01/04/2026 NERV_US — Stock Titan
[Form 4] Minerva Neurosciences, Inc. Insider Trading Activity
01/04/2026 NERV_US — MarketBeat
Minerva Neurosciences (NERV) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $NERV
31/03/2026 NERV_US — GlobeNewswire
Minerva Neurosciences Announces First Patient Screened in
31/03/2026 NERV_US — Stock Titan
No approved drug exists for these schizophrenia symptoms; Minerva starts Phase 3
31/03/2026 NERV_US — Seeking Alpha
Minerva Neurosciences: Plodding Ahead After Another Roluperidone Delay In Negative Symptoms Of Schizophrenia
31/03/2026 NERV_US — Stock Titan
NERV (NASDAQ: NERV) Form 144 shows 156,410-share sale, 650,000 offered
31/03/2026 NERV_US — Stock Titan
Federated Hermes sells 97,549 NERV shares (NASDAQ: NERV) in Form 144 notice
31/03/2026 NERV_US — Stock Titan
Federated Hermes sells 3,658 shares of NERV common stock (NASDAQ: NERV)
31/03/2026 NERV_US — NTB Kommunikasjon
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
25/03/2026 NERV_US — Investing News Network
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
25/03/2026 NERV_US — GlobeNewswire
Minerva Neurosciences Presents Data from its Open-label
25/03/2026 NERV_US — Yahoo Finance ES ← EN
Minerva Neurosciences presenta datos de su ensayo de seguridad de etiqueta abierta que evalúa la roluperidona coadministrada con olanzapina en SIRS 2026
25/03/2026 NERV_US — Stock Titan
Schizophrenia drug combo showed no safety issues as Phase 3 starts
12/03/2026 NERV_US — Investing News Network
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
12/03/2026 NERV_US — Yahoo Finance
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
12/03/2026 NERV_US — The Manila Times
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
11/03/2026 NERV_US — Yahoo Finance
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates

Página 2 de 3

keyboard_arrow_up